{"ok":true,"entity":{"id":"bristol-myers-squibb","name":"Bristol Myers Squibb","entityType":"company","officialName":"Bristol-Myers Squibb Company","canonicalName":"Bristol Myers Squibb","displayName":"Bristol Myers Squibb","category":"大手製薬企業","shortDescription":"米国ニュージャージー州に本社を置くバイオ医薬品企業。腫瘍、血液疾患、免疫疾患、心血管疾患、神経科学を重点領域とする。Opdivo・Eliquisなど大型製品の独占期間満了に対応し、Cobenfy等の新規製品群への転換を進めている。","primaryCluster":"pharmaceuticals","parentEntity":null,"verificationStatus":"draft","website":"https://www.bms.com","updatedAt":"2026-08-06T01:18:46.240Z","secondaryClusters":[],"alias":["BMS"],"searchKeywords":["腫瘍","血液疾患","免疫疾患","心血管疾患","神経科学"]},"referenceIndex":["P-01-001","P-02-001","P-04-001","P-06-001","P-01-002"]}